Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Tocilizumab for Patients With Cancer and COVID-19 Disease [Phase 2]
Phase 2 trial evaluating tocilizumab in cancer patients with COVID-19 was terminated; results were posted in June 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Clinical Use of Stem Cells for the Treatment of Covid-19 [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the clinical use of stem cells for Covid-19 and related pneumonia, including multiple organ failure, …
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Effectiveness Trial of Day-care vs. Usual Care of Severe Pneumonia & Malnutrition in Children [Phase 4]
Phase 4 trial update comparing Day-care versus usual care for severe pneumonia and malnutrition in children; status unavailable.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation [Phase 2]
Phase 2 trial evaluating mavrilimumab to reduce progression of acute respiratory failure in COVID-19 pneumonia with systemic hyper-inflammat…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 [Phase 3]
Phase 3 clinical trial evaluating the efficacy of chloroquine or hydroxychloroquine in treating pneumonia caused by SARS-CoV-2/COVID-19 has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: SILtuximab in Viral ARds (SILVAR) Study [Phase 3]
Phase 3 trial of SILtuximab in viral ARDS (SILVAR) was terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating efficacy and safety of a treatment relative to standard of care in patients with COVID-19 pneumonia; current status…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients. [Phase 4]
Phase 4 trial update comparing antiviral and anti-inflammatory drugs in COVID-19 patients with pneumonia.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer [Phase 4]
Phase 4 clinical trial evaluating observation and treatment of pulmonary microthrombosis in childhood pneumonia with elevated D-dimer; study…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: 3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi [Phase 4]
Phase 4 trial comparing 3 days of amoxicillin to placebo for fast-breathing pneumonia in children in Malawi has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: 3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi [Phase 4]
Phase 4 trial comparing 3 days vs 5 days of amoxicillin for chest-indrawing pneumonia in children in Malawi has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children [Phase 4]
Phase 4 trial update evaluating beta-lactam antimicrobial therapy for community-acquired pneumonia in children has completed with results po…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing safety, pharmacokinetics and pharmacodynamics of Kamada anti-SARS-CoV-2 therapy in COVID-19 patients ha…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System [Phase 3]
Phase 3 trial update evaluating clarithromycin for severe infections by modulating the immune system in sepsis and pneumonia.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia [Phase 3]
Phase 3 clinical trial update for tifacogin in severe community-acquired pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia [Phase 2]
Phase 2 clinical trial update on inhaled exosome therapy for COVID-19-associated pneumonia; safety and efficacy data not yet clearly reporte…
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Protecting From Pneumococcus in Early Life (The PROPEL Trial) [Phase 3]
Phase 3 clinical trial update focusing on protection from pneumococcus in early life (PROPEL Trial).
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment [Phase 3]
Phase 3 trial update of IVIG (Bioven) for COVID-19 with severe pneumonia shows completion of the study.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 [Phase 4]
Phase 4 clinical trial update on nebulized heparin for COVID-19 and pneumonia; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy [Phase 3]
A Phase 3 trial comparing high versus low doses of low-molecular-weight heparin in hospitalized patients with severe COVID-19 pneumonia and …
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 3]
Phase III trial update for a 13-valent pneumococcal conjugate vaccine in healthy infants completed.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) [Phase 2]
Phase 2 trial update evaluating captopril for efficacy in COVID-19 patients with pneumonia (CAPTOCOVID).
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Baricitinib Therapy in COVID-19 [Phase 2, Phase 3]
Clinical trial update on baricitinib therapy for COVID-19 with pneumonia conducted in Phase 2 and Phase 3 stages; status completed.
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of a 15-valent pneumococcal conjugate vaccine in healthy 2- to 3-month-old infants.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 [Phase 3]
Phase 3 trial update on hydroxychloroquine for COVID-19 shows efficacy and safety data from completed study.